The inflammatory response to cardiopulmonary bypass - Should it be treated?

G. E. Hill

Research output: Contribution to journalArticlepeer-review


Proinflammatory cytokines, including tumor necrosis factor (TNF) α and the interleukins, are important in the metabolic response to injury or infection. Although the importance of cytokine release during cardiopulmonary bypass (CPB) is not fully appreciated, increasing numbers of publications present evidence that cytokine release during CPB is detrimental. In addition, endogenous inhibitors of cytokine function, including TNF-soluble receptor and interleukin 1 receptor antagonist, are released in response to elevated proinflammatory cytokine levels during and after CPB. The involvement of these endogenous inhibitors in the pathophysiology of proinflammatory cytokine-induced solid organ injury after CPB remains to be defined.

Original languageEnglish (US)
Pages (from-to)229-235
Number of pages7
JournalSeminars in Cardiothoracic and Vascular Anesthesia
Issue number3
StatePublished - Jan 1 2001

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Anesthesiology and Pain Medicine


Dive into the research topics of 'The inflammatory response to cardiopulmonary bypass - Should it be treated?'. Together they form a unique fingerprint.

Cite this